Imran Talat 4
4 · Rani Therapeutics Holdings, Inc. · Filed May 23, 2025
Insider Transaction Report
Form 4
Imran Talat
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-05-23+1,053,000→ 1,053,000 totalExercise: $0.62Exp: 2035-05-22→ Class A Common Stock (1,053,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option vest as follows: 1/48th of the shares subject to the option vest monthly over four years from May 23, 2025.